Skip to main content
# Title Department Research Member Research Year
71 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2023
72 Value of FoxO3a Gene Expression in Pediatric Acute Lymphoblastic Leukemia Department of Clinical Pathology Madonna Refaat Ayoub 2023
73 Visceral and Subcutaneous Fat, Muscle Mass, and Liver Volume as Non-invasive Predictors of the Progress of Non-alcoholic Fatty Liver Disease Department of Radiology Dr. Omar Mustafa Mahmoud Mohamed 2023
74 Effective and Elaborative Induction Program for Mitigating Myths and Misconceptions Linked to Hematopoietic Stem Cell Transplantation in a Resource Limited SettingEffective and Elaborative Induction Program for Mitigating Myths and Misconceptions Linked t Department of Pediatric Oncology Mahmoud Motaz Elzembely 2023
75 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2023
76 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Shimaa Hassan Shabaan Hassan 2023
77 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Dr. Badawy, Mohammed Ahmed Mohammed 2023
78 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Prof. Hesham Mahmoud Mohamed Mahmoud 2023
79 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Abdelrahman Kamel Fathy Mohammed 2023
80 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Dr. Ahmed Refaat Abdel Zaher Mubarak 2023